Steward Partners Investment Advisory, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 39 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 3.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$02,0000.0%0.00%
Q2 2019$0
-100.0%
2,0000.0%0.00%
Q3 2018$1,0000.0%2,0000.0%0.00%
Q2 2018$1,0000.0%2,0000.0%0.00%
Q1 2018$1,0002,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,825,000$1,206,0000.39%
Zhang Financial LLC 45,000$33,0000.02%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 472,553$313,0000.01%
MEITAV INVESTMENT HOUSE LTD 127,062$85,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 324,479$215,000,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$200,0000.00%
Renaissance Technologies 1,993,500$1,318,0000.00%
WEDBUSH SECURITIES INC 15,000$10,0000.00%
TWO SIGMA SECURITIES, LLC 57,127$38,0000.00%
Psagot Value Holdings Ltd. 29,193$20,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders